LGT Capital Partners LTD. Has $45.25 Million Holdings in Intuitive Surgical, Inc. $ISRG

LGT Capital Partners LTD. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 79.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 101,180 shares of the medical equipment provider’s stock after buying an additional 44,901 shares during the quarter. Intuitive Surgical comprises approximately 2.2% of LGT Capital Partners LTD.’s investment portfolio, making the stock its 17th biggest holding. LGT Capital Partners LTD.’s holdings in Intuitive Surgical were worth $45,251,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. SteelPeak Wealth LLC lifted its holdings in Intuitive Surgical by 28.7% during the 3rd quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock valued at $18,781,000 after purchasing an additional 9,364 shares during the last quarter. Amalgamated Bank raised its position in shares of Intuitive Surgical by 2.2% in the second quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock valued at $44,311,000 after buying an additional 1,772 shares in the last quarter. Atlantic Union Bankshares Corp increased its holdings in Intuitive Surgical by 19.3% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock valued at $10,179,000 after buying an additional 3,676 shares during the period. Bessemer Group Inc. lifted its stake in Intuitive Surgical by 89.3% during the second quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock worth $428,386,000 after purchasing an additional 371,806 shares during the last quarter. Finally, World Investment Advisors lifted its holdings in shares of Intuitive Surgical by 238.3% in the third quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider’s stock worth $2,415,000 after acquiring an additional 3,803 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on ISRG shares. The Goldman Sachs Group restated a “buy” rating and issued a $714.00 price target on shares of Intuitive Surgical in a research report on Friday, January 9th. Wells Fargo & Company increased their price target on Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. Finally, Raymond James Financial raised their target price on Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a report on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $617.23.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 464 shares of Intuitive Surgical stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $548.49, for a total transaction of $254,499.36. Following the completion of the sale, the senior vice president owned 131 shares of the company’s stock, valued at $71,852.19. The trade was a 77.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Gary S. Guthart sold 2,800 shares of the business’s stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $531.52, for a total value of $1,488,256.00. Following the completion of the sale, the director owned 15,720 shares of the company’s stock, valued at $8,355,494.40. The trade was a 15.12% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 56,189 shares of company stock valued at $30,785,441. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $492.10 on Tuesday. The firm has a market capitalization of $174.76 billion, a P/E ratio of 62.37, a PEG ratio of 3.90 and a beta of 1.65. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $603.88. The business has a fifty day moving average price of $534.53 and a 200-day moving average price of $511.16.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating the consensus estimate of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.21 earnings per share. Sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.